de Melker Hester E, Versteegh Florens G A, Schellekens Joop F P, Teunis Peter F M, Kretzschmar Mirjam
Department of Infectious Diseases Epidemiology, National Institute of Public Health and the Environment, Bilthoven, The Netherlands.
J Infect. 2006 Aug;53(2):106-13. doi: 10.1016/j.jinf.2005.10.020. Epub 2005 Dec 15.
Bordetella pertussis circulates even in highly vaccinated populations. There is a considerable amount of infection in adults. For designing more effective vaccination schedules it is important to quantify the age-dependent relation between the number of notified cases and the number of infections.
We used a statistical relationship between the time since infection and the IgG antibody titers against pertussis toxin, derived from a longitudinal data set, to estimate time since infection for all individuals in a cross-sectional population-based study (1995-1996) based on their titers. Age-specific incidence of infection with B. pertussis was calculated and compared with the age-distribution of notified cases of pertussis in 1994-1996.
Estimated incidence of infection was 6.6% per year for 3-79-year olds, annual incidence of notified cases 0.01%. Estimated age-specific incidence of infection was lowest for 3-4-year olds (3.3%) and increased gradually up to the age of 20-24 years (10.8%). The number of notified cases was highest for 3-9-year olds.
In the Dutch population B. pertussis infections occur more frequently and in elder age-categories then suggested by notifications. Mathematical modeling could explore what booster vaccination strategies are most effective in reducing severe disease among not (completely) vaccinated infants.
百日咳博德特氏菌即使在高疫苗接种率人群中也有传播。成人中有相当数量的感染病例。为设计更有效的疫苗接种计划,量化报告病例数与感染数之间的年龄依赖关系很重要。
我们利用一个纵向数据集得出的感染后时间与抗百日咳毒素IgG抗体滴度之间的统计关系,基于横断面人群研究(1995 - 1996年)中所有个体的抗体滴度来估计其感染后时间。计算百日咳博德特氏菌感染的年龄别发病率,并与1994 - 1996年百日咳报告病例的年龄分布进行比较。
3至79岁人群的估计年感染发病率为6.6%,报告病例的年发病率为0.01%。估计3至4岁儿童的年龄别感染发病率最低(3.3%),并逐渐上升至20至24岁时达到最高(10.8%)。报告病例数在3至9岁儿童中最多。
在荷兰人群中,百日咳博德特氏菌感染比报告病例所显示的更频繁,且发生在年龄更大的人群中。数学建模可以探索哪些加强免疫策略在降低未(完全)接种疫苗婴儿的严重疾病方面最有效。